Trial Profile
A phase 2 study of SR-0379 in patients with cutaneous ulcer (pressure ulcer, diabetic ulcer)
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 07 Dec 2021
Price :
$35
*
At a glance
- Drugs SR 0379 (Primary)
- Indications Ulcer
- Focus Adverse reactions; Therapeutic Use
- Sponsors Shionogi
- 03 Jul 2018 New trial record